SCHEMBL27780765

SCHEMBL27780765

Cc1ccc(CN2CCC(C(=O)Nc3ccc(C#N)nn3)CC2)cc1C(F)(F)F

nearest known ligand 0.45

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PHGDH O43175 1/20 0.45
ACKR3 P25106 10/20 0.45
UBE2M P61081 1/20 0.44
DCUN1D1 Q96GG9 1/20 0.44
ACHE P22303 1/20 0.42
CCR3 P51677 2/20 0.40
ABL1 P00519 1/20 0.40
KDR P35968 1/20 0.40
PRKAB2 O43741 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA2 P54646 1/20 0.40
PRKAA1 Q13131 1/20 0.40
PRKAG3 Q9UGI9 1/20 0.40
PRKAG2 Q9UGJ0 1/20 0.40
PRKAB1 Q9Y478 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27780766 0.90 DRD2 (0.45) ACKR3ACHECCR3KDR
SCHEMBL27759410 0.88 DRD2 (0.45) ACKR3ACHECCR3
SCHEMBL27780761 0.88 ALDH1A1 (0.45) ACKR3ACHECCR3
SCHEMBL2821574 0.85 DRD2 (0.54) PHGDHACHEPRKAA2
SCHEMBL27780768 0.85 PRKAB2 (0.51) ACKR3PRKAB2PRKAG1PRKAA2PRKAA1
SCHEMBL27759411 0.84 ACHE (0.56) ACHE
SCHEMBL27759404 0.84 UBE2M (0.52) ACKR3UBE2MDCUN1D1
SCHEMBL27780767 0.82 ERCC1 (0.50) ACHECCR3PRKAA2
SCHEMBL27780762 0.81 ACHE (0.44) ACKR3UBE2MDCUN1D1ACHECCR3
SCHEMBL27780769 0.81 ACHE (0.47) ACKR3ACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101547915-B Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists JANSSEN PHARMACEUTICA NV 2013-08-21 CN disclosed
CN-101547915-A Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists JANSSEN PHARMACEUTICA NV (BE) 2009-09-30 CN disclosed